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Summary Congenital abnormalities of the nail are rare conditions that are most frequently
associated with congenital ectodermal syndromes involving several of the epidermal
appendages including the skin, teeth, hair and nails. Isolated recessive nail dysplasia
(IRND) is much rarer but has recently been recognized as a condition resulting in
20-nail dystrophy in the absence of other cutaneous or extracutaneous findings.
A few case reports have identified mutations in the Frizzled 6 (FZD6) gene in families
presenting with abnormal nails consistent with IRND. These reports have high-
lighted the role of Wnt–FZD signalling in the process of nail formation. We report
three families presenting with features of IRND, in whom we identified mutations in
FZD6, including one previously unreported mutation.
Congenital abnormalities of the nail are rare disorders,
often associated with congenital ectodermal syndromes
involving several of the epidermal appendages includ-
ing the skin, teeth, hair and nails. This is the case for
pachyonychia congenita (PC), a disorder of keratiniza-
tion and blistering involving the nails and skin.
Despite its rarity, PC is perhaps one of the better
understood, researched and reported congenital nail
syndromes, whereas isolated recessive nail dysplasia
(IRND) is much rarer and less well understood.1
The molecular pathways involved in the signalling
for nail development are multiple and complex, thus
mutations of genes involved in this process ultimately
result in nail malformation.2 The Frizzled (FZD) gene
family encodes FZD receptors, which act as receptors
for the Wnt signalling proteins. The role of the
Wnt–FZD pathway is increasingly recognized in nail
formation. Recently, mutations in the FZD6 gene have
been identified as a cause of IRND [OMIM #614157;
(NDNC)-10] in several families.3–6 We report three
families in which individuals presented with a similar
pattern of nail deformities, and were investigated for
mutations of the FZD6 gene.
Report
All genetic studies were carried out after appropriate
ethics approval, and the studies complied with the
Declaration of Helsinki Principles. All participants (or
their parent/guardians as appropriate) provided writ-
ten informed consent.
Family 1 was a consanguineous Pakistani family;
three of the five siblings had abnormalities of their
nails, inherited in an autosomal recessive pattern
(Fig. 1). The nail problem was noticed in all affected
siblings at 6–8 weeks of age. In the 3 affected siblings,
all 20 nails were similarly affected, but there was a
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(c) Normal FZD6, exon 4 (d) FZD6 p.Gly422Asp (heterozygous) (e) FZD6 p.Gly422Asp (homozygous)
(a)
(b)
Figure 1 Family 1. (a) Twenty-nail dystrophy in three siblings with marked subungual hyperkeratosis and onychogryphosis; the
remaining two siblings in the family had normal nails. (b) The inheritance in this family follows an autosomal recessive pattern. (c–e)
Sequence analysis: (c) a normal FZD6 sequence covering nucleotides c.1255-1275; (d) equivalent region from the unaffected mother
showing the heterozygous mutation c.1265G>A, leading to the missense mutation p.Gly422Asp; (e) equivalent region from one of the
affected children, showing the same mutation in the homozygous state.
ª 2016 The Authors. Clinical and Experimental Dermatology published by
John Wiley & Sons Ltd on behalf of British Association of Dermatologists,
North American Clinical Dermatologic Society and St Johns Dermatological Society.
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variable degree of nail dystrophy, manifesting primar-
ily as subungual hyperkeratosis and onycholysis. The
hyperkeratosis resulted in onychogryphosis and a claw
appearance of several nails, together with yellow ony-
chauxis of the plates. Nail growth was slow with occa-
sional painful lifting and dropping off. The results of
skin and systemic examinations were otherwise unre-
markable. Both of the parents and the other two sib-
lings had normal nails. Genomic DNA was obtained
from blood samples, and amplified and sequenced for
the FZD6 gene (accession number NM_003506) as
described by Wilson et al.6 A homozygous missense
mutation p.Gly422Asp; c.1265G>A was identified in
the FZD6 gene in all three affected siblings (Fig. 1).
The unaffected parents were found to be heterozygous
carriers for this mutation, and one unaffected sibling
had the wild-type gene (the other unaffected sibling
was not tested as no sample was obtained). This muta-
tion has been previously reported as the cause of IRND
in another family, also of Pakistani origin.4
Family 2 was from a small village in Turkey and
there was first-degree consanguinity between the
maternal grandparents (Fig. 2). The probands were two
young girls who were cousins, and both presented with
isolated nail dystrophy. Patient 1 developed overgrowth
and abnormal conformation of all nails when she was
3 months old. There was a family history of psoriasis
on her maternal side. Patient 2 presented at 3 years of
age with similar features. Using direct DNA sequencing,
both affected children were found to be homozygous for
an 8 bp deletion mutation, p.Gly559Aspfs*16;
c.1676_1683delGAACCAGC, in FZD6 (Fig. 2). The
mutation causes a frameshift and creates a premature
stop codon at position 16 of the new reading frame.
The unaffected parents of each child were heterozygous
carriers for the mutation. This mutation has not been
previously reported; it was not found in the dbSNP
database, the 1000 Genomes Project or the NHLBI
Exome Sequencing Project (http://evs.gs.washing-
ton.edu/EVS/). The in silico prediction tool, Mutation
Taster, predicted this to be a disease-causing variant,
and that it will lead to a truncated protein or to protein
loss via nonsense-mediated decay.
Family 3 was a Turkish family living in Germany.
The proband was a 3-year-old boy born to consan-
guineous unaffected parents. He was born with thick-
ening of and dark edges to his nails (Fig. 3). By the
age of 3 years there was marked elevation of the nail
plate and he had already lost several nails. This family
was screened by whole exome sequencing (Genomic
Sequencing Unit, Dundee, UK), and the affected child
was found to be homozygous for a deletion mutation
p.Gly559Aspfs*16 in FZD6, the same mutation as that
identified in Family 2 (Fig. 2). The mutation was con-
firmed by Sanger sequencing, and both parents were
found to be heterozygous carriers.
Nail development begins around week 9 of the
embryonic period, starting at the dorsal aspect of the
distal end of the digits with mesenchymal condensa-
tion, which is shortly followed by the development of
the transverse nailfold.7 Beneath the transverse
nailfold the matrix primordium, containing proliferat-
ing keratinocytes, forms. This process initiates the
development of the nail bed with the expression of
epithelial keratins, while the keratinocytes eventually
undergo apoptosis, resulting in the keratin cytoskele-
ton of the nail plate. The nail plate is known to origi-
nate in the apical matrix of the nail along with the
keratogenous zone of the ventral matrix.8 The embry-
onic development of the ectodermal appendages,
including the nails, relies on the Wnt–FZD signalling
pathway.4 FZD6 is expressed in the keratogenous zone
of the ventral matrix, where there is staggered expres-
sion of various keratins.3 It has therefore been postu-
lated that FZD6 mutations could lead to
disorganization of the staggered expression of keratins,
resulting in nail dysplasia.
The action of FZD6 at the molecular level in claw
development in mice was investigated by Cui et al.,9
and their findings suggested a regulatory role for
FZD6-mediated Wnt signalling in the differentiation
process of claw/nail formation. Recently, mutations in
the FZD6 gene have been identified as a key culprit
in the development of IRND in several families.3–6 In
2011, Frojmark et al.5 reported two consanguineous
Pakistani families with some members affected by
isolated nail dysplasia. The authors confirmed that
homozygous FZD6 mutations (p.Glu584* and
p.Arg511Cys) result in nail deformities through
reduced or aberrant FZD6 and nonfunctioning FZD-
Wnt pathways. A homozygous nonsense FZD6 muta-
tion (p.Glu584*) was also found in all affected members
of two further families of Pakistani origin with IRND.3
The authors concluded that absence of nails is due to
loss of activation of the Wnt/b-catenin signalling cas-
cade whereas nail overgrowth is caused by loss of inhi-
bition of the Wnt/b-catenin signalling cascade. Four
additional unrelated families presenting with 20-nail
dystrophy caused by FZD6 mutations have been
described (homozygous p.Gly422Asp, homozygous
p.Arg509* and compound heterozygous p.Arg96Cys/
Glu438Lys), confirming the findings of previous stud-
ies.4,6 To date, five different mutations in FZD6 have
been reported in eight families.
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In this paper we report 3 further families with
mutations in FZD6 causing IRND. The initial clinical
impression in all three families was PC. However, this
was later rejected as all other ectodermal tissues
showed no abnormalities. The recessive pattern of
inheritance was also not consistent with PC. It became
evident that the clinical findings were more in keeping
with IRND, and genetic analysis was carried out. DNA
sequence analysis identified one previously unreported
mutation and one known mutation in FZD6. Families
2 and 3 are both of Turkish origin, although not
knowingly related. The presenting clinical features of
(e) FZD6 p.Gly559Aspfs*16 (homozygous)(c) FZD6 exon 6 normal (d) FZD6 p.Gly559Aspfs*16 (heterozygous)
(a)
(b)
Figure 2 Family 2. (a) The two girls from Family 2 presented with a similar pattern of nail deformities; (b) inheritance for isolated
recessive nail dysplasia in this family follows an autosomal recessive pattern (black). An incidental family history of psoriasis (shaded)
was also noted. (c–e) Sequence analysis: (c) normal FZD6 sequence showing nucleotides c.1669-1689; (d) equivalent region from the
unaffected mother showing the heterozygous mutation c.1676_1683delGAACCAGC, leading to the frameshift mutation
p.Gly559Aspfs*16; (e) equivalent region from one of the affected children, showing the same mutation in the homozygous state. This
mutation was also identified in Family 3.
ª 2016 The Authors. Clinical and Experimental Dermatology published by
John Wiley & Sons Ltd on behalf of British Association of Dermatologists,
North American Clinical Dermatologic Society and St Johns Dermatological Society.
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all affected individuals appear consistently similar to
those of previous reports, with subungual hyperkerato-
sis, yellow onychauxis and a claw appearance of all
20 nails without any other cutaneous or appendageal
signs.3–6,10 The pattern of autosomal recessive inheri-
tance in all three families is in keeping with published
case reports of IRND.
Our results enhance the existing but limited knowl-
edge regarding the role of FZD6 mutations and the
Wnt pathway in the pathogenesis of IRND. Dermatolo-
gists need to be aware of this entity, and be able to dif-
ferentiate it from PC and other hereditary nail
disorders. Genetic analysis of FZD6 should be consid-
ered in all cases of isolated nail dysplasia. This will
enable accurate genetic counselling of the family and
avoidance of unnecessary treatments that have been
used for PC. Further studies into the role of the Wnt
signalling pathway are needed to provide more clarity
of the pathophysiological picture of congenital nail
deformities.
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Learning points
• Anomalies in Wnt–FZD signalling pathways
during early embryonic life result in nail dyspla-
sia.
• IRND has been described recently in humans as
a rare form of inherited nail dysplasia.
• Dystrophy of all 20 nails in the absence of
cutaneous or appendageal features is a clue to
the diagnosis.
• Six mutations in FZD6 have so far been
reported (including the one reported in this
paper).
• Genetic analysis of FZD6 should be considered
in cases of sporadic or known recessive cases of
isolated nail dysplasia.
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